Information About GARDASIL 9

+

GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) helps protect individuals ages 9 to 45 against the following diseases caused by 9 types of HPV: cervical, vaginal, and vulvar cancers in females, anal cancer, certain head and neck cancers, such as throat and back of mouth cancers and genital warts in both males and females.


 

Important Safety Information

 

Having trouble paying for your Merck medicine? Merck may be able to help. Visit merckhelps.com

Copyright © 2021 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved.

This site is intended only for residents of the United States, its territories, and Puerto Rico. US-GSL-02507 11/20

Anyone who is allergic to the ingredients of GARDASIL 9 or GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], including those severely allergic to yeast, should not receive the vaccine. GARDASIL 9 was not studied in women who knew they were pregnant.

The side effects include pain, swelling, redness, itching, bruising, bleeding, and a lump where you got the shot, headache, fever, nausea, and dizziness. Fainting can happen after getting GARDASIL 9. Sometimes people who faint can fall and hurt themselves. For this reason, your health care professional may ask you or your child to sit or lie down for 15 minutes after you get GARDASIL 9. Some people who faint might shake or become stiff.